AcelRx Pharmaceuticals Cultura da Companhia

Mr. Anil N. Dasu, also known as Badri, has been the Chief Engineering Officer of AcelRx Pharmaceuticals, Inc. since July 2007. Mr. Dasu joined AcelRx in September 2007 from Anesiva Inc. (formerly, Algorx Pharmaceuticals Inc.) where he served as Vice President of Medical Device Engineering since December 2005. He also served as Vice President, Manufacturing and Process Development from 2002 to December 2005. Prior to joining Anesiva, He was employed at PowderJect Technologies Inc., a pharmaceutical company, from 2000 to 2002, serving in a number of positions including Vice President, Manufacturing, Process Development and Device Development. From January 2000 to July 2000. He served as Director of manufacturing and process development at PowderJect Pharmaceuticals. From 1996 to 2002 He served in a variety of engineering positions including Director of Process Development and Product Transfer at Metrika Inc., a maker of micro optical, disposable medical diagnostics. From 1992 to 1996, He was an Engineer at Cygnus Inc., a maker of drug delivery systems. He is a member of the American Institute of Chemical Engineers and a member of AAMI. He holds a B.E. degree in Chemical Engineering from the University of Mangalore, India and M.S. degree in Chemical Engineering from the University of Tulsa.

Mr. Lawrence G. Hamel, also known as Larry, has been the Chief Development Officer of AcelRx Pharmaceuticals, Inc. since September 2006. Mr. Hamel has over 28 years of experience in pharmaceutical development with primary focus on development of oral drug delivery systems. Since 1986, he has personally managed or directed 43 IND submissions and 8 new NDA submissions from inception through commercialization. He has a thorough understanding of the Regulatory and Development processes in both the US and EU. During his tenure at ALZA, he held a number of new technologies to commercial readiness, including Push-Stick and patterned delivery designs. Mr. Hamel holds a BS degree in Biology from the University of Michigan.

Dr. Pamela Pierce Palmer, M.D., Ph.D., has been the Chief Medical Officer of AcelRx Pharmaceuticals, Inc. since co-founded it in July 2005. Dr. Palmer serves as Director of UCSF PainCARE at Center for Advanced Research and Education. Dr. Palmer specialized clinically in treating acute and chronic pain and also is a leader in opioid and serotonin receptor research, as well as peripheral pain and inflammation mechanisms. She Co-founded Omeros Medical Systems, Inc. and serves as its Consultant. She serves as a Professor of Anesthesia and Perioperative Care at the University of California - San Francisco. She has been a Director of AcelRx Pharmaceuticals, Inc. since July 2005. Dr. Palmer received her M.D. from Stanford University and her Ph.D. degree from the Stanford Department of Neuroscience.

Raffi Asadorian serves as the CFO of AcelRx Pharmaceuticals, Inc.. Raffi started at AcelRx Pharmaceuticals, Inc. in Aug of 2017. Raffi currently resides in the San Francisco Bay Area.

Paul Howe serves as the Vice President Sales of AcelRx Pharmaceuticals, Inc.. Paul started at AcelRx Pharmaceuticals, Inc. in Apr of 2017. Paul currently resides in the San Francisco Bay Area.

Pamela Palmer serves as the Chief Medical Officer and Cofounder of AcelRx Pharmaceuticals, Inc.. Pamela started at AcelRx Pharmaceuticals, Inc. in July of 2005. Pamela currently resides in the San Francisco Bay Area.

Karen DiDonato serves as the Executive Director, Medical Affairs of AcelRx Pharmaceuticals, Inc.. Karen started at AcelRx Pharmaceuticals, Inc. in March of 2014. Karen currently resides in the San Francisco Bay Area.